You do not have permission to delete messages in this group
Copy link
Report message
Show original message
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
to the-sequenom-d...@googlegroups.com
QNatal Advanced is based, in part, on intellectual property licensed by Quest Diagnostics from Sequenom as part of an agreement, announced in June 2014. Unlike Sequenom's MaterniT21, QNatal Advanced provides the option to opt out of receiving information on gender and microdeletions, which can provide complex and limited actionable information, and facilitates direct ordering and reporting of results via Quest's Care360 connectivity solution. It also reports results as Yes/No for the presence of relevant trisomies and other abnormalities, as compared to other industry reports that score findings on a likelihood scale.
"We've taken the best of the Sequenom technology and added to it our own expertise and innovation, based on our deep experience in genomics and women's health," Dr. Strom said. "The result is an offering that, while medically equivalent, may have greater potential to provide clear, actionable information to help each patient understand her personal risk."